Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Urocortin ELISA Kit (AC2773)
Cat.#: ASET-1362
Specifications
Description Mouse Urocortin ELISA Kit allows for the in vitro quantitative determination of mouse Urocortin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1323 Rat Glutamine Synthetase ELISA Kit (AC2734) Quantitative inquiry ASET-1890 Mouse GDNF ELISA Kit (AC3301) Quantitative inquiry ASET-1898 Monkey beta Nerve Growth Factor ELISA Kit (AC3309) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-2334 Mouse ACTH ELISA Kit (AC3745) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-2302 Human KCNN4 ELISA Kit (AC3713) Quantitative inquiry ASET-1131 Human SOX2 ELISA Kit (AC2542) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry ASET-1651 Vasopressin ELISA Kit (AC3062) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket